Sign in

CIK 0001061983

  • Large accelerated filer

CYTOKINETICS INC

Sign in to watch
Ticker
CYTK
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
943291317
Phone
+1 650-624-3000
Business address
350 OYSTER POINT BOULEVARD, ., SOUTH SAN FRANCISCO, CA, 94080
  1. 4 Planned sale EVP Research & Development sold 3,500 shares at $77.37 ($270,795)
  2. 4 Planned sale Director sold 4,032 shares at $75.00 ($302,400)
  3. 4 Planned sale EVP, Chief Financial Officer sold 23,906 shares at $76.87 ($1,837,654)
  4. 4 Planned sale Director sold 20,000 shares at $75.97 ($1,519,400)
  5. 4 Planned sale EVP, Chief Commercial Officer sold 11,333 shares at $77.25 ($875,474)
  6. 4 Planned sale EVP, Chief Commercial Officer sold 15,857 shares at $65.00 ($1,030,705)
  7. 4 Planned sale EVP, Chief Commercial Officer sold 15,000 shares at $63.26 ($948,900)
  8. 4 Planned sale President & CEO sold 7,500 shares at $59.62 ($447,150)
  9. 4 Planned sale EVP Research & Development sold 3,500 shares at $65.69 ($229,915)
  10. 4 Grant or award Director acquired 95 shares (grant or award)
  11. 4 Grant or award Director acquired 95 shares (grant or award)
  12. 4 Grant or award Director acquired 191 shares (grant or award)
  13. 4 Grant or award Director acquired 325 shares (grant or award)
  14. 4 Grant or award Director acquired 191 shares (grant or award)
  15. 4 Grant or award Director acquired 191 shares (grant or award)
  16. 4 Planned sale EVP, Chief Commercial Officer sold 7,449 shares at $66.02 ($491,783)
  17. 4 Planned sale President & CEO sold 7,500 shares at $65.38 ($490,350)
  18. 4 Planned sale EVP Research & Development sold 4,500 shares at an average $65.11 ($292,985)
  19. 4 Planned sale President & CEO sold 7,500 shares at $66.63 ($499,725)
  20. 4 Planned sale EVP, Chief Commercial Officer sold 3,639 shares at $65.00 ($236,535)

Page 4 of 70 · 1,399 filings